CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 80.96% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Moderna rallies past $100 billion valuation ahead of quarterly results

By Reuters News

** Shares of Moderna MRNA.O rise 10.2% to $251.67

** At current levels, Moderna's market capitalization topped the $100 bln mark, adding roughly $8 bln in market value from the previous close

** Last month, late-stage data showed vaccine intismeran, being jointly developed by Moderna and Merck MRK.N, plus Merck's Keytruda cut the risk of melanoma death or recurrence by 42% and the risk of the cancer's spread by 38%, compared with Keytruda alone

** Moderna is scheduled to report third-quarter results on Friday, with investors expected to focus on vaccine partnership payments, updates on the cancer vaccine

** Stock trades about 1% below its record intraday high of $254.48 touched last month

** Including session moves, MRNA up over eight-fold this year

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.